Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / David M. Holtzman
Person

David M. Holtzman

Tracked across 1 events · 6 articles · First seen Feb 19, 2026 · Last active Feb 23, 2026

Sentiment
30
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
6 30
Tech
Blood Test Predicts Alzheimer's Onset
Impact: David M. Holtzman is a co-founder of C2N Diagnostics and a coauthor of the study, contributing to the development of the blood test.
Feb 19, 2026 · 6 articles
ERGEN INTELLIGENCE
Track David M. Holtzman live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.